Stelara 90 MG/ML syringeml
Ended Awarded
- Contract number
- SPE2DX25F6XKY
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Medical Supply Chain
Troop Support, Department of Defense
- Obligated
- $65,000
Award facts
- Contract value 100% obligated
- $64,999.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $65,000 for Stelara 90 mg/ml syringes on June 17, 2025, with completion scheduled for July 10, 2025. This firm fixed-price delivery order was issued without set-aside designation and is funded by the Defense Logistics Agency (DLA) under the Medical Supply Chain program. The award represents a continuation of DMS Pharmaceutical Group's substantial role in the federal pharmaceutical supply chain, leveraging its position as a critical supplier to Department of Defense healthcare facilities nationwide.
This delivery order falls under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA valued at $500 million and valid through November 2026 under the SPE2DB program. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products supporting military health facilities. Stelara, a biologic immunosuppressant medication, represents one of many specialized pharmaceutical products distributed through this contract vehicle. DMS Pharmaceutical Group's consistent success in securing federal pharmaceutical contracts, combined with its woman-owned small business status and established presence in federal procurement markets since 2001, positions the company as a key distribution partner for military medical supply needs.
Quick answers
Who was awarded contract SPE2DX25F6XKY?
SPE2DX25F6XKY was awarded to DMS Pharmaceutical Group Inc. by Medical Supply Chain (Troop Support) on June 17, 2025.
How much is contract SPE2DX25F6XKY worth?
The government has obligated $65,000 on SPE2DX25F6XKY.
Is contract SPE2DX25F6XKY an order under another contract?
Yes. SPE2DX25F6XKY is a delivery order under SPE2DX15D9168, an indefinite delivery contract.
Was contract SPE2DX25F6XKY competed?
The extent of competition for SPE2DX25F6XKY was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award